Surveillance of Complicated Mpox Cases Unresponsive to Oral Tecovirimat in Los Angeles County, 2022

J Infect Dis. 2024 Mar 26;229(Supplement_2):S249-S254. doi: 10.1093/infdis/jiad517.

Abstract

The Los Angeles County Department of Public Health established a surveillance system to identify complicated (advanced human immunodeficiency virus [HIV] or hospitalized) mpox cases. From 1 August to 30 November 2022, we identified 1581 mpox cases, of which 134 (8.5%) were complicated. A subset of 8 cases did not recover after either initiating or completing a course of oral tecovirimat. All 8 patients were HIV positive and had advanced HIV (CD4 count <200 cells/μL). We identified 8 distinct mutations previously associated with tecovirimat resistance in specimens collected from 6 patients. Ongoing surveillance of viral evolution requires close coordination between health departments and frontline providers.

Keywords: advanced HIV; drug resistance; mpox; surveillance; tecovirimat.

MeSH terms

  • Benzamides
  • HIV Seropositivity*
  • Humans
  • Isoindoles
  • Los Angeles
  • Mpox (monkeypox)*

Substances

  • Benzamides
  • Isoindoles